Is the U.S. manufacturing reshoring wave real, or is it just headlines?

It's mixed. While the ISM PMI reached 52.7 in March 2026 and over 100 companies pledged reshoring, real manufacturing construction (excluding semiconductors) grew only 2.3% in real terms through March 2026. Manufacturing employment has declined 1% since tariffs took effect. The reshoring trend is real in specific sectors but not a broad-based boom. The article identifies pharma, food, flatbed, and automotive as the sectors with genuine domestic investment and immediate freight implications.

What makes pharmaceutical freight different, and why is it an opportunity for small carriers?

Pharma facilities generate consistent, high-frequency movements of regulated inputs, controlled substances, packaging, and finished products—most temperature-sensitive and requiring chain-of-custody documentation. This is relationship-dependent, high-value-per-mile freight, not commodity spot freight. The compliance requirements (facility access protocols, regulatory documentation, temperature control) create a barrier to entry that protects carriers willing to invest in proper positioning. Small carriers with established compliance infrastructure can access lanes that less-prepared competitors cannot.

How should a regional carrier identify pharmaceutical reshoring opportunities?

The article recommends geographic targeting: identify pharmaceutical manufacturing facilities (both existing and announced expansions) within a 300-mile radius of your home base. Use the Reshoring Initiative's database at reshorenow.org to find announced domestic projects by state and industry. Cross-reference these against your operating region to identify potential accounts most competitors have not contacted. This geographic specificity is more effective than competing in national spot markets.

Is food and beverage reshoring driven by new facility investment, or is the opportunity in route changes?

Both. Food and beverage has always been domestic-rooted (agricultural inputs, regional processing, time-sensitive distribution), but current conditions—supply chain instability, tariff pressure on imported ingredients and packaging, and shifting distribution patterns—are driving new facility investment and routing changes. C.H. Robinson's December 2025 outlook notes that the Southeast, with tightened capacity and steady food manufacturing activity, is a region where small carriers with consistent service records on regional lanes command real value from shippers who cannot afford disruption.

What's the strategic difference between winning pharma freight versus food and beverage freight?

Pharma freight requires compliance infrastructure and direct shipper relationships; it's won through preparation and credibility. Food and beverage freight is already moving but experiencing route changes and seasonal surges; it's won through documented regional service reliability and capacity reliability during peak demand. Pharma is a barrier-to-entry play; food and beverage is an execution-and-reliability play. Different positioning strategies are required for each.

Manufacturing

High Impact

Four Reshoring Freight Lanes Where Small Carriers Win

While U.S. manufacturing headlines tout a reshoring boom, the reality is more nuanced. Manufacturing construction spending (excluding semiconductors) grew only 2.3% in real terms through March 2026, and 64% of manufacturers have no reshoring plans. However, four specific industry sectors—pharmaceutical, food and beverage, flatbed-adjacent construction materials, and regional automotive supply—are genuinely investing in domestic production and generating actionable freight opportunities that are not yet locked into major carrier routing guides. Pharmaceutical manufacturing represents the most concrete opportunity for small carriers. With Eli Lilly's $27 billion domestic investment, Merck's vaccine programs, and Johnson & Johnson's $55 billion pledge, new facilities are coming online across Indiana, North Carolina, Wisconsin, and Alabama. Pharma freight is relationship-dependent, compliance-intensive, and moves high-value temperature-sensitive products on short regional lanes. The compliance barrier to entry—chain-of-custody documentation, facility access protocols, and regulatory requirements—functions as a protective moat for carriers willing to invest in proper positioning and direct shipper outreach. Food and beverage represents a different but equally significant opportunity. Unlike manufacturing sectors that can be offshored, food production is inherently domestic and time-sensitive. Current supply chain instability, tariff pressure on imported ingredients and packaging, and shifting distribution patterns are driving new facility investments and routing changes. Regional carriers with documented service records on temperature-sensitive, just-in-time lanes are positioned to capture value that national networks cannot replicate at scale. Small carriers should focus geographic specificity—identifying announced facilities within 300 miles of their home base—rather than competing in national spot markets.

May 13, 2026Source: FreightWaves4 min read

The Reshoring Headline vs. the Freight Reality

U.S. manufacturing headlines are unmistakable: in April 2026, the White House declared that "American Manufacturing Is Roaring Back," citing an ISM Manufacturing PMI of 52.7—a multi-year high. Over 100 companies publicly pledged reshoring or domestic expansion. But for supply chain professionals managing regional carrier networks and freight strategy, the real story is far more specific and far less universally positive.

Manufacturing construction spending (excluding semiconductors) rose only 2.3% in real terms between February 2025 and March 2026. Manufacturing employment has declined 1% since widespread tariffs took effect. The Kearney Reshoring Index shows the U.S. remains well below levels indicating a structural reshoring trend. A December 2025 Institute for Supply Management survey found that 64% of manufacturers have no reshoring plans—compared to just 36% actively reshoring or planning to.

The critical insight: there is no across-the-board manufacturing boom generating universal freight gains. What exists instead is a specific set of industry sectors where domestic production investment is genuinely underway and generating truck freight not yet locked into major carrier routing guides. For regional carriers and supply chain teams, this distinction between narrative and operational reality is the difference between strategic opportunity and wasted pursuit.

Pharmaceutical: Compliance as Competitive Moat

Pharmaceutical manufacturing represents the most concrete reshoring opportunity with immediate freight implications. Eli Lilly's $27 billion domestic investment includes facilities in Indiana, North Carolina, Wisconsin, and Alabama. Merck operates active domestic vaccine and biologics programs. Johnson & Johnson pledged $55 billion in 2025, with production ramping across a five-to-seven-year timeline.

But pharmaceutical freight operates under fundamentally different economics than commodity trucking. A large pharma facility doesn't generate the volume freight of a consumer goods distribution center. Instead, it generates consistent, high-frequency movements of regulated inputs, controlled substances, packaging components, and finished product—most temperature-sensitive, most requiring chain-of-custody documentation, most moving on short regional lanes between facilities, distribution points, and specialty hubs.

This is relationship-dependent, compliance-intensive, high-value-per-mile freight. The carriers who have invested in proper compliance infrastructure, documented safety records, and direct shipper outreach can walk into these conversations credibly. Those who haven't simply cannot get in the door. The compliance requirement functions as a protective moat: every certification met, every documentation system perfected is a barrier that less-prepared competitors cannot clear. For small, well-positioned carriers, this barrier is asset-protecting rather than merely obstructive.

The tactical entry point is geographic specificity. Using databases like reshorenow.org, a carrier should identify announced pharmaceutical facilities within 300 miles of their home base—existing operations plus expansion sites. That list represents potential accounts most competitors have never contacted. This beats national spot-market competition decisively.

Food & Beverage: Volume Meets Regional Reliability

Food and beverage manufacturing generates more domestically rooted truck freight than nearly any other sector—not because of recent reshoring, but because food cannot be offshored the way electronics can. The inputs are agricultural, processing is regional, and distribution is time-sensitive by necessity.

What has changed is the operational context. Supply chain instability, tariff pressure on imported ingredients and packaging, and shifting distribution patterns are driving new facility investment and route changes. C.H. Robinson's December 2025 freight outlook noted that food and beverage seasons drive Q2 rate increases from an elevated baseline, with shippers actively evaluating carrier relationships heading into seasonal surges. The Southeast, which experienced significant capacity tightening through 2025 due to carrier exits combined with steady food manufacturing activity, is a region where small carriers with consistent, documented service records on regional lanes command real economic value.

Unlike pharma's compliance-first entry model, food and beverage success hinges on execution and reliability. Shippers cannot afford disruption on temperature-sensitive, just-in-time runs. A carrier that can demonstrate consistent on-time performance, equipment reliability, and regional lane knowledge becomes strategically essential—and pricing power follows.

Strategic Positioning: Where Small Carriers Win

For supply chain teams and carrier networks, the strategic imperative is clear: stop chasing the national reshoring headline; start winning in the four sectors where investment is real and freight is available. Pharma requires compliance investment and shipper credibility. Food and beverage requires regional reliability and documented service records. Flatbed-adjacent construction materials and regional automotive supply chains follow similar logic—geographic specificity, relationship-based positioning, and operational excellence.

The carriers and supply chain operations that map their capabilities against these specific opportunities, rather than betting on a broad manufacturing boom, will capture disproportionate value in the next 18-36 months. The headline wave is real, but the actionable freight flows are narrow—and that narrowness is precisely what creates competitive opportunity.

Source: FreightWaves

#reshoring

#domestic-manufacturing

#pharma-logistics

#small-carriers

#regional-freight

#supply-chain-strategy

#trucking-opportunities

#manufacturing-investment

#cold-chain

#compliance-logistics

Frequently Asked Questions

What This Means for Your Supply Chain

Simulation Suggestion

this month

What if a new pharmaceutical facility ramps production faster than expected, creating a surge in temperature-controlled freight demand?

Model the scenario where a new Eli Lilly or Merck facility in the Southeast reaches 80% operational capacity 6 months ahead of schedule, requiring 40% more weekly temperature-controlled truckload movements than current baseline. How would this affect regional carrier utilization, pricing power, and equipment positioning? What fleet size and compliance infrastructure would be needed to capture 15% of that volume?

Run this scenario

Simulation Suggestion

this month

What if tariff pressures force food manufacturers to consolidate sourcing geographically, creating new regional distribution lanes?

Model the scenario where food and beverage manufacturers, responding to tariffs on imported ingredients and packaging, build new regional distribution points instead of relying on centralized national networks. Assume 3-5 new food manufacturing or distribution hubs open in the Southeast and Midwest over the next 18 months, each generating 50-100 weekly refrigerated/temperature-controlled shipments. How would this shift regional carrier lane utilization, pricing, and competitive positioning versus national carriers?